Saphetor announced a research partnership with the Exome Consortium of University College London (UCL), led by Dr. Vincent Plagnol.
As part of a series of service agreements with UCL-affiliated research groups, Prof. Michel Michaelides and his team will use Saphetor’s precision medicine platform to investigate eye disorders in patients. By partnering with world-class researchers and clinicians at UCL, Saphetor seeks to improve genetic diagnoses that will enhance prognosis counseling for patients and identify those who may be eligible for specific clinical trials.
Dr. Vincent Plagnol is a Reader in statistical genetics at the UCL Genetics Institute with a focus on translational research. His work on rare disease genetics is widely published, both in pioneering methodological advances and significant molecular discoveries.
“We are looking forward to working with Saphetor, as their fast turnaround and comprehensive platform will ensure timely and accurate results in our wide range of research projects,” Dr. Plagnol said.
Prof. Michel Michaelides is a highly-cited Professor of Ophthalmology at University College London, based at the Institute of Ophthalmology, a premier vision research center. He is also a Consultant Ophthalmologist at Moorfields Eye Hospital, one of the most respected eye hospitals in the world.
"We are pleased to work with Saphetor, as their advanced analytical capabilities are already driving new findings in congenital eye conditions," Prof. Michaelides said.